A business in context
EL research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-15 | Nunez Arturo | A · Grant / award | Stock Units (Share Payout) | 15.56 | 96.25 |
| 2026-09-15 | Strong Dana | A · Grant / award | Stock Units (Share Payout) | 2.88 | 96.25 |
| 2026-09-15 | Hyman Jennifer | A · Grant / award | Stock Units (Share Payout) | 16.03 | 96.25 |
| 2026-09-15 | Tejada Jennifer | A · Grant / award | Stock Units (Share Payout) | 16.03 | 96.25 |
| 2026-09-15 | Long Annabelle Yu | A · Grant / award | Stock Units (Share Payout) | 2.88 | 96.25 |
| 2026-09-15 | Zinterhofer Eric Louis | A · Grant / award | Stock Units (Share Payout) | 10.23 | 96.25 |
| 2026-09-15 | Zinterhofer Eric Louis | A · Grant / award | Stock Units (Cash Payout) | 8.41 | 96.25 |
| 2026-09-15 | ZANNINO RICHARD F | A · Grant / award | Stock Units (Share Payout) | 10.89 | 96.25 |
| 2026-09-15 | ZANNINO RICHARD F | A · Grant / award | Stock Units (Share Payout) | 38.9 | 96.25 |
| 2026-09-15 | BARSHEFSKY CHARLENE | A · Grant / award | Stock Units (Share Payout) | 86.09 | 96.25 |
| 2026-09-15 | FRIBOURG PAUL J | A · Grant / award | Stock Units (Cash Payout) | 152.95 | 96.25 |
| 2026-09-15 | FRIBOURG PAUL J | A · Grant / award | Stock Units (Share Payout) | 52.85 | 96.25 |
| 2026-09-15 | STERNLICHT BARRY S | A · Grant / award | Stock Units (Share Payout) | 68.05 | 96.25 |
| 2026-09-15 | STERNLICHT BARRY S | A · Grant / award | Stock Units (Cash Payout) | 174.27 | 96.25 |
| 2026-09-15 | LAUDER JANE | A · Grant / award | Stock Units (Share Payout) | 2.88 | 96.25 |
| 2026-09-15 | LAUDER GARY M | A · Grant / award | Stock Units (Share Payout) | 16.1 | 96.25 |
| 2026-09-15 | Lauder William P | A · Grant / award | Stock Units (Share Payout) | 2.88 | 96.25 |
| 2026-09-14 | FRIBOURG PAUL J | S · Sale | Class A Common Stock | 14777.0 | 97.17 |
| 2026-09-14 | FRIBOURG PAUL J | S · Sale | Class A Common Stock | 16137.0 | 98.79 |
| 2026-09-14 | FRIBOURG PAUL J | S · Sale | Class A Common Stock | 27086.0 | 98.35 |
| 2026-09-11 | FRIBOURG PAUL J | S · Sale | Class A Common Stock | 45000.0 | 96.78 |
| 2026-09-09 | BARSHEFSKY CHARLENE | S · Sale | Class A Common Stock | 3775.0 | 98.82 |
| 2026-09-09 | BARSHEFSKY CHARLENE | M · Exercise / conversion | Class A Common Stock | 4697.0 | 78.36 |
| 2026-09-09 | BARSHEFSKY CHARLENE | M · Exercise / conversion | Stock Option (Right to Buy) | 4697.0 | n/a |
| 2026-08-28 | La Lande Rashida | S · Sale | Class A Common Stock | 7766.0 | 103.32 |
| 2026-08-27 | Lammers Hendrik Rene | A · Grant / award | Restricted Stock Units (Share Payout) | 7909.0 | n/a |
| 2026-08-27 | Lammers Hendrik Rene | A · Grant / award | Restricted Stock Units (Share Payout) | 9416.0 | n/a |
| 2026-08-27 | Lammers Hendrik Rene | A · Grant / award | Stock Option (Right to Buy) | 28820.0 | n/a |
| 2026-08-27 | Bowes Michael | A · Grant / award | Restricted Stock Units (Share Payout) | 4896.0 | n/a |
| 2026-08-27 | Bowes Michael | A · Grant / award | Stock Option (Right to Buy) | 17841.0 | n/a |
| 2026-08-27 | de la Faverie Stephane | A · Grant / award | Stock Option (Right to Buy) | 137238.0 | n/a |
| 2026-08-27 | de la Faverie Stephane | A · Grant / award | Restricted Stock Units (Share Payout) | 37661.0 | n/a |
| 2026-08-27 | Hertzmark Hudis Jane | A · Grant / award | Stock Option (Right to Buy) | 61153.0 | n/a |
| 2026-08-27 | Hertzmark Hudis Jane | A · Grant / award | Restricted Stock Units (Share Payout) | 16782.0 | n/a |
| 2026-08-27 | Webster Meridith | A · Grant / award | Stock Option (Right to Buy) | 19213.0 | n/a |
| 2026-08-27 | Webster Meridith | A · Grant / award | Restricted Stock Units (Share Payout) | 5273.0 | n/a |
| 2026-08-27 | La Lande Rashida | M · Exercise / conversion | Class A Common Stock | 14357.0 | n/a |
| 2026-08-27 | La Lande Rashida | F · Tax / exercise payment | Class A Common Stock | 6591.0 | 106.06 |
| 2026-08-27 | La Lande Rashida | M · Exercise / conversion | Restricted Stock Units (Share Payout) | 14357.0 | n/a |
| 2026-08-27 | La Lande Rashida | A · Grant / award | Stock Option (Right to Buy) | 37053.0 | n/a |
| 2026-08-27 | La Lande Rashida | A · Grant / award | Restricted Stock Units (Share Payout) | 10169.0 | n/a |
| 2026-08-27 | Canevari Roberto | A · Grant / award | Restricted Stock Units (Share Payout) | 8869.0 | n/a |
| 2026-08-27 | Canevari Roberto | A · Grant / award | Stock Option (Right to Buy) | 32320.0 | n/a |
| 2026-08-27 | Shrivastava Akhil | A · Grant / award | Restricted Stock Units (Share Payout) | 10169.0 | n/a |
| 2026-08-27 | Shrivastava Akhil | A · Grant / award | Stock Option (Right to Buy) | 37053.0 | n/a |
| 2026-08-21 | La Lande Rashida | M · Exercise / conversion | Class A Common Stock | 5564.0 | 92.87 |
| 2026-08-21 | La Lande Rashida | S · Sale | Class A Common Stock | 5564.0 | 99.55 |
| 2026-08-21 | La Lande Rashida | M · Exercise / conversion | Stock Option (Right to Buy) | 5564.0 | 92.87 |
| 2026-08-21 | ZANNINO RICHARD F | M · Exercise / conversion | Class A Common Stock | 4697.0 | 78.36 |
| 2026-08-21 | ZANNINO RICHARD F | M · Exercise / conversion | Stock Option (Right to Buy) | 4697.0 | n/a |
Identity & relationships
SEC issuer · 0001001250ESTEE LAUDER COMPANIES INC
Estée Lauder CompaniesBobbi BrownClinique Laboratories, LLCDECIEMDr. Jart+Make-up Art CosmeticsOrigins Natural Resources, Inc.Tom FordAvedaLe LaboBumble and bumbleJo Malone LondonPrescriptivesAramis (fragrance)Lab SERIES
Search names and former names
View Wikidata identity and references ↗
- Estée Lauder Companies · subsidiary · wikidata
- Estee Lauder Companies · alias · wikidata
- Estee Lauder · alias · wikidata
- Bobbi Brown · subsidiary · wikidata
- Bobbi Brown Cosmetics · subsidiary · wikidata
- The Cosmetics Company Store · subsidiary · wikidata
- Clinique Laboratories, LLC · subsidiary · wikidata
- Clinique · subsidiary · wikidata
- Clinique Laboratories · subsidiary · wikidata
- DECIEM · subsidiary · wikidata
- Dr. Jart+ · subsidiary · wikidata
- Make-up Art Cosmetics · subsidiary · wikidata
- M·A·C · subsidiary · wikidata
- MAC Cosmetics · subsidiary · wikidata
- Origins Natural Resources, Inc. · subsidiary · wikidata
- Origins Natural Resources product · subsidiary · wikidata
- Origins Natural Resources · subsidiary · wikidata
- Origins · subsidiary · wikidata
- Origins product line · subsidiary · wikidata
- Origins product · subsidiary · wikidata
- Tom Ford · subsidiary · wikidata
- Aveda · subsidiary · wikidata
- Le Labo · subsidiary · wikidata
- Le Labo Fragrances · subsidiary · wikidata
- Bumble and bumble · subsidiary · wikidata
- Bumble and bumble Products, LLC · subsidiary · wikidata
- Bumble and bumble Products · subsidiary · wikidata
- Jo Malone London · subsidiary · wikidata
- Jo Malone · subsidiary · wikidata
- Prescriptives · subsidiary · wikidata
- Prescriptives LLC · subsidiary · wikidata
- Aramis (fragrance) · subsidiary · wikidata
- Aramis (perfume) · subsidiary · wikidata
- Lab SERIES · subsidiary · wikidata
- Lab Series Skincare for Men · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2025-06-30 | $14.33B | $15.19B |
| 2024-06-30 | $15.61B | $16.99B |
| 2023-06-30 | $15.91B | $17.89B |
| 2022-06-30 | $17.74B | $21.19B |
| 2021-06-30 | $16.21B | $20.76B |
| 2020-06-30 | $14.29B | $18.72B |
| 2019-06-30 | $14.86B | $19.77B |
| 2018-06-30 | $13.68B | $18.58B |